CLINICAL_TRIALS
trial_result
· 2024-02-16
Clinical Trial Update: Study Comparing Treatment With Alluzience vs Reconstituted Toxin [Phase 4]
Summary
A phase 4 trial comparing Alluzience with reconstituted toxin for treatment of glabellar frown lines has completed with results posted in 2024.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Galderma R&D | Conditions: Glabellar Frown Lines | Phase 4 | Status: COMPLETED | Results posted: 2024-02-16